VRE resistance mechanisms

VRE Basics - The Stubborn Germs

• Enterococci: Gram-positive cocci, part of normal gut flora. Intrinsically resistant to many antibiotics (e.g., cephalosporins).
  • Enterococcus faecalis: More common, generally more susceptible.
  • Enterococcus faecium: Less common, but more likely to be resistant.
• Vancomycin-Resistant Enterococci (VRE): Strains that have acquired resistance to vancomycin, a last-resort antibiotic.
• Clinical Impact: Major cause of nosocomial infections, particularly UTIs, bacteremia, and endocarditis in immunocompromised patients.

⭐ E. faecium is inherently more resistant and the predominant species in VRE infections compared to E. faecalis.

Vancomycin's MO - Wall-Wrecker at Work

Vancomycin physically obstructs bacterial cell wall synthesis. It's a large glycopeptide that directly binds to the $D-Alanine-D-Alanine$ termini of nascent peptidoglycan chains.

• Mechanism: Forms a cap on the $D-Ala-D-Ala$ substrate.
• Effect: This steric hindrance blocks two crucial enzymes:
  • Transglycosylase: Halts the elongation of the glycan chain.
  • Transpeptidase (a PBP): Prevents cross-linking of the peptide side chains.
• Outcome: Inhibition of peptidoglycan synthesis → compromised cell wall integrity → cell lysis.

⭐ Because of its large size, vancomycin cannot penetrate the porin channels of gram-negative bacteria, making them intrinsically resistant.

The van Genes - Resistance Masterminds

Vancomycin resistance in enterococci (VRE) is primarily due to the alteration of the drug's target site in the bacterial cell wall. This is orchestrated by van gene clusters.

• Mechanism: The van operon codes for enzymes that synthesize a different peptidoglycan precursor.
  • The normal target, $D-Ala-D-Ala$, is replaced with $D-Ala-D-Lac$.
  • This substitution prevents vancomycin from binding effectively, as it disrupts crucial hydrogen bonds.

⭐ The vanA and vanB gene clusters are the most clinically significant and are typically located on mobile genetic elements (plasmids, transposons), facilitating their spread.

• Vancomycin-Resistant Enterococci (VRE) resistance is primarily due to the alteration of the peptidoglycan synthesis pathway.
• The terminal dipeptide target D-Ala-D-Ala is modified to D-Ala-D-Lac (conferred by VanA and VanB genes) or D-Ala-D-Ser (VanC).
• This change dramatically reduces the binding affinity of vancomycin, rendering it ineffective.
• VanA provides high-level resistance to both vancomycin and teicoplanin.
• Resistance genes are often located on mobile plasmids and transposons, facilitating horizontal gene transfer.